Synthesis of 1-aryl-3-(3,4-dihydro-2H-chromen-5-yl) ureas as TNF-α inhibitors

Chinese Chemical Letters

Volumn 18, Issue 8, 2007, Pages 905-908

  Zhou, Xin Ming ^b   Zheng, Zhi Bing ^a   Liu, Hong Ying ^a   Zhong, Wu ^a   Xiao, Jun Hai ^a   Wang, Li Li ^a   Li, Song ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

1 Aryl 3 (3,4 dihydro 2H chromen 5 yl) ureas; p38 MAPK inhibitor; Synthesis

Indexed keywords

EID: 34447634660     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2007.06.014     Document Type: Article

References (12)

1. Dinarello C.A. Curr. Opin. Immunol. 3 (1991) 941
2. Feldmann M., Brennan F.M., et al. Annu. Rev. Immunol. 14 (1996) 397
3. Taylor P.C. Intern. Med. 42 (2003) 15
4. Lee J.C., Laydon J.E., et al. Nature 372 (1994) 739
5. Herlaar E., Brown Z., et al. Mol. Med. Today 5 (1999) 439
6. Lee J.C., Kumar S., et al. Immunopharmercology 47 (2000) 185
7. Branger J., Weijer S., et al. J. Immunol. 168 (2002) 4070
8. Rengan J., Capolino A., Cirillo P.F., et al. J. Med. Chem. 46 22 (2003) 4676
9. Pargellis C.A., Tong L., et al. Nat. Struct. Biol. 9 (2002) 268
10. Maleski R.J., Kluge M., and Sicker D. Synth. Commun. 25 15 (1995) 2327
11. Blifeld C., Prehn J.L., Jordan C., et al. Transplantation 51 2 (1991) 498
12. Regan J., Breitfeler S., et al. J. Med. Chem. 45 14 (2002) 2994